Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2008-11-28

Original market date: See footnote 1

1997-06-16

Product name:

VIOKASE POWDER

DIN:

02230020 Electronic product monograph is not available

Company:

AXCAN PHARMA INC
597 Laurier Blvd
Mont St-Hilaire
Quebec
Canada J3H 6C4

Class:

Human

Dosage form(s):

Powder

Route(s) of administration:

Oral

Number of active ingredient(s):

3

Schedule(s):

OTC

 

American Hospital Formulary Service (AHFS): See footnote 3

56:16.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)

Active ingredient group (AIG) number:See footnote5

0302964006

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
AMYLASE 70000 UNIT / 0.7 G
LIPASE 16800 UNIT / 0.7 G
PROTEASE 70000 UNIT / 0.7 G
Version 4.0.3

"Page details"

Date modified: